FDA's fall 2023 vaccine plan

Today a much anticipated meeting took place at the FDA. Their external scientific committee—called VRBPAC—voted unanimously to update the COVID-19 vaccine in anticipation of the fall 2023-2024 respiratory illness season.

Here are your Cliff notes.

Why update the COVID-19 vaccines?

We could keep the same vaccine formula this fall, but several reasons we …